RCM
ELV icon

Riverhead Capital Management’s Elevance Health ELV Stock Holding History

Riverhead Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.85M Buy
7,713
+4,150
+116% +$1.14M 0.07% 356
2019
Q2 		$1M Sell
3,563
-12,535
-78% -$3.42M 0.04% 491
2019
Q1 		$4.62M Sell
16,098
-2,466
-13% -$713K 0.19% 154
2018
Q4 		$4.88M Sell
18,564
-7,637
-29% -$2.1M 0.22% 119
2018
Q3 		$7.18M Sell
26,201
-33,250
-56% -$8.63M 0.26% 99
2018
Q2 		$14.2M Sell
59,451
-34,292
-37% -$7.94M 0.56% 24
2018
Q1 		$20.6M Buy
93,743
+18,230
+24% +$4.28M 0.87% 8
2017
Q4 		$17M Buy
75,513
+30,990
+70% +$6.6M 0.72% 14
2017
Q3 		$8.45M Buy
44,523
+13,110
+42% +$2.5M 0.4% 52
2017
Q2 		$5.91M Buy
31,413
+11,753
+60% +$2.11M 0.29% 87
2017
Q1 		$3.25M Buy
19,660
+1,347
+7% +$214K 0.18% 167
2016
Q4 		$2.63M Sell
18,313
-33,227
-64% -$4.45M 0.16% 185
2016
Q3 		$6.46M Buy
51,540
+31,340
+155% +$4.05M 0.42% 50
2016
Q2 		$1.12M Sell
20,200
-319,752
-94% -$43.8M 0.04% 403
2016
Q1 		$47.2M Sell
339,952
-102,302
-23% -$13.7M 0.67% 21
2015
Q4 		$61.7M Buy
442,254
+123,379
+39% +$17M 0.9% 11
2015
Q3 		$44.6M Sell
318,875
-77,528
-20% -$11.7M 0.7% 22
2015
Q2 		$65.1M Sell
396,403
-104,870
-21% -$16.8M 0.98% 10
2015
Q1 		$77.4M Sell
501,273
-117,274
-19% -$16.7M 1.17% 4
2014
Q4 		$77.7M Buy
618,547
+43,085
+7% +$5.32M 1.18% 5
2014
Q3 		$68.8M Buy
575,462
+98,453
+21% +$11.3M 1.18% 5
2014
Q2 		$51.3M Buy
477,009
+10,553
+2% +$1.09M 0.96% 10
2014
Q1 		$46.4M Buy
466,456
+211,199
+83% +$19.1M 1.02% 11
2013
Q4 		$23.6M Buy
255,257
+241,257
+1,723% +$21.4M 0.63% 37
2013
Q3 		$1.17M Hold
14,000
– – 0.04% 336
2013
Q2 		$1.15M Buy
+14,000
New +$1.05M 0.04% 324

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Riverhead Capital Management's ELV Position: Q3 2019 in Review

Riverhead Capital Management increased its Elevance Health (ELV) stake by 116% in Q3 2019, buying an estimated $1.14M and bringing the position to 7,713 shares worth $1.85M. The position accounts for 0.07% of the portfolio, ranked #356.

Riverhead Capital Management first reported a position in ELV in Q2 2013 and has held it in 26 quarters since. The position peaked at $77.7M in Q4 2014. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Riverhead Capital Management held 7,713 shares of Elevance Health worth $1.85M as of Q3 2019.
  • Riverhead Capital Management bought 4,150 Elevance Health shares in Q3 2019, an estimated $1.14M.
  • Elevance Health made up 0.07% of Riverhead Capital Management's portfolio in Q3 2019, its #356 holding.
  • Riverhead Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Elevance Health position peaked at $77.7M in Q4 2014.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.